Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events.
Ayuso JM, Monge R, Martínez-González A, Virumbrales-Muñoz M, Llamazares GA, Berganzo J, Hernández-Laín A, Santolaria J, Doblaré M, Hubert C, Rich JN, Sánchez-Gómez P, Pérez-García VM, Ochoa I, Fernández LJ. Ayuso JM, et al. Neuro Oncol. 2017 Apr 1;19(4):503-513. doi: 10.1093/neuonc/now230. Neuro Oncol. 2017. PMID: 28062831 Free PMC article.
Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
Sepúlveda-Sánchez JM, Vaz MÁ, Balañá C, Gil-Gil M, Reynés G, Gallego Ó, Martínez-García M, Vicente E, Quindós M, Luque R, Ramos A, Ruano Y, Pérez-Segura P, Benavides M, Sánchez-Gómez P, Hernández-Laín A. Sepúlveda-Sánchez JM, et al. Neuro Oncol. 2017 Oct 19;19(11):1522-1531. doi: 10.1093/neuonc/nox105. Neuro Oncol. 2017. PMID: 28575464 Free PMC article. Clinical Trial.
Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab.
Manneh Kopp RA, Sepúlveda-Sánchez JM, Ruano Y, Toldos O, Pérez Núñez A, Cantero D, Hilario A, Ramos A, de Velasco G, Sánchez-Gómez P, Hernández-Laín A. Manneh Kopp RA, et al. Clin Transl Oncol. 2019 Oct;21(10):1413-1423. doi: 10.1007/s12094-019-02070-6. Epub 2019 Mar 15. Clin Transl Oncol. 2019. PMID: 30877636
Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma.
Hernández-SanMiguel E, Gargini R, Cejalvo T, Segura-Collar B, Núñez-Hervada P, Hortigüela R, Sepúlveda-Sánchez JM, Hernández-Laín A, Pérez-Núñez A, Sanz E, Sánchez-Gómez P. Hernández-SanMiguel E, et al. Oxid Med Cell Longev. 2019 Aug 5;2019:9719730. doi: 10.1155/2019/9719730. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31467641 Free PMC article.
The EGFR-TMEM167A-p53 Axis Defines the Aggressiveness of Gliomas.
Segura-Collar B, Gargini R, Tovar-Ambel E, Hernández-SanMiguel E, Epifano C, Pérez de Castro I, Hernández-Laín A, Casas-Tintó S, Sánchez-Gómez P. Segura-Collar B, et al. Cancers (Basel). 2020 Jan 14;12(1):208. doi: 10.3390/cancers12010208. Cancers (Basel). 2020. PMID: 31947645 Free PMC article.
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.
Cejalvo T, Gargini R, Segura-Collar B, Mata-Martínez P, Herranz B, Cantero D, Ruano Y, García-Pérez D, Pérez-Núñez Á, Ramos A, Hernández-Laín A, Martín-Soberón MC, Sánchez-Gómez P, Sepúlveda-Sánchez JM. Cejalvo T, et al. Cancers (Basel). 2020 Nov 2;12(11):3230. doi: 10.3390/cancers12113230. Cancers (Basel). 2020. PMID: 33147752 Free PMC article.
53 results